These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 29564568)

  • 1. "Ruffled border" formation on a CaP-free substrate: A first step towards osteoclast-recruiting bone-grafts materials able to re-establish bone turn-over.
    Merolli A; Fung S; Murthy NS; Pashuck ET; Mao Y; Wu X; Steele JAM; Martin D; Moghe PV; Bromage T; Kohn J
    J Mater Sci Mater Med; 2018 Mar; 29(4):38. PubMed ID: 29564568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Osteoclasts in bone metabolism].
    Hakeda Y; Kumegawa M
    Kaibogaku Zasshi; 1991 Aug; 66(4):215-25. PubMed ID: 1759556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation of an osteoclast antigen and ruffled border on giant cells formed in response to resorbable substrates.
    Webber D; Osdoby P; Hauschka P; Krukowski M
    J Bone Miner Res; 1990 Apr; 5(4):401-10. PubMed ID: 2343780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Osteoclastic resorption of calcium phosphate coatings applied with electrostatic spray deposition (ESD), in vitro.
    Siebers MC; Matsuzaka K; Walboomers XF; Leeuwenburgh SC; Wolke JG; Jansen JA
    J Biomed Mater Res A; 2005 Sep; 74(4):570-80. PubMed ID: 16025470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mandibular Jaw Bone Regeneration Using Human Dental Cell-Seeded Tyrosine-Derived Polycarbonate Scaffolds.
    Zhang W; Zhang Z; Chen S; Macri L; Kohn J; Yelick PC
    Tissue Eng Part A; 2016 Jul; 22(13-14):985-93. PubMed ID: 27369635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro osteoclast resorption of bone substitute biomaterials used for implant site augmentation: a pilot study.
    Taylor JC; Cuff SE; Leger JP; Morra A; Anderson GI
    Int J Oral Maxillofac Implants; 2002; 17(3):321-30. PubMed ID: 12074446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biological aspects of altered bone remodeling in multiple myeloma and possibilities of pharmacological intervention.
    Kupisiewicz K
    Dan Med Bull; 2011 May; 58(5):B4277. PubMed ID: 21535989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Osteoclast differentiation from human blood precursors on biomimetic calcium-phosphate substrates.
    Ciapetti G; Di Pompo G; Avnet S; Martini D; Diez-Escudero A; Montufar EB; Ginebra MP; Baldini N
    Acta Biomater; 2017 Mar; 50():102-113. PubMed ID: 27940198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. S 12911-2 inhibits osteoclastic bone resorption in vitro.
    Takahashi N; Sasaki T; Tsouderos Y; Suda T
    J Bone Miner Res; 2003 Jun; 18(6):1082-7. PubMed ID: 12817762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of mineralizing cartilage in osteoclast and osteoblast recruitment.
    van de Wijngaert FP; Schipper CA; Tas MC; Burger EH
    Bone; 1988; 9(2):81-8. PubMed ID: 3044406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of Human Dental Pulp and Endothelial Cell Seeded Tyrosine-Derived Polycarbonate Scaffolds for Robust
    Zhang W; Saxena S; Fakhrzadeh A; Rudolph S; Young S; Kohn J; Yelick PC
    Front Bioeng Biotechnol; 2020; 8():796. PubMed ID: 32766225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A role for osteocalcin in osteoclast differentiation.
    Glowacki J; Rey C; Glimcher MJ; Cox KA; Lian J
    J Cell Biochem; 1991 Mar; 45(3):292-302. PubMed ID: 2066381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Osteoclast resorption of beta-tricalcium phosphate controlled by surface architecture.
    Davison NL; ten Harkel B; Schoenmaker T; Luo X; Yuan H; Everts V; Barrère-de Groot F; de Bruijn JD
    Biomaterials; 2014 Aug; 35(26):7441-51. PubMed ID: 24927681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disordered osteoclast formation and function in a CD38 (ADP-ribosyl cyclase)-deficient mouse establishes an essential role for CD38 in bone resorption.
    Sun L; Iqbal J; Dolgilevich S; Yuen T; Wu XB; Moonga BS; Adebanjo OA; Bevis PJ; Lund F; Huang CL; Blair HC; Abe E; Zaidi M
    FASEB J; 2003 Mar; 17(3):369-75. PubMed ID: 12631576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Osteoblasts mediate insulin-like growth factor-I and -II stimulation of osteoclast formation and function.
    Hill PA; Reynolds JJ; Meikle MC
    Endocrinology; 1995 Jan; 136(1):124-31. PubMed ID: 7828521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incorporation of RANKL promotes osteoclast formation and osteoclast activity on β-TCP ceramics.
    Choy J; Albers CE; Siebenrock KA; Dolder S; Hofstetter W; Klenke FM
    Bone; 2014 Dec; 69():80-8. PubMed ID: 25245204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Degradation of hydroxyapatite in vivo and in vitro requires osteoclastic sodium-bicarbonate co-transporter NBCn1.
    Riihonen R; Nielsen S; Väänänen HK; Laitala-Leinonen T; Kwon TH
    Matrix Biol; 2010 May; 29(4):287-94. PubMed ID: 20079835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Foreign Body Giant Cell Cannot Resorb Bone, But Dissolves Hydroxyapatite Like Osteoclasts.
    ten Harkel B; Schoenmaker T; Picavet DI; Davison NL; de Vries TJ; Everts V
    PLoS One; 2015; 10(10):e0139564. PubMed ID: 26426806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Bone and bone related biochemical examinations. Bone and collagen related metabolites. Regulatory mechanisms of osteoclast differentiation and function].
    Takahashi N
    Clin Calcium; 2006 Jun; 16(6):940-47. PubMed ID: 16751689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Osteoblasts mediate thyroid hormone stimulation of osteoclastic bone resorption.
    Britto JM; Fenton AJ; Holloway WR; Nicholson GC
    Endocrinology; 1994 Jan; 134(1):169-76. PubMed ID: 8275930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.